{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:09:06Z","timestamp":1756858146385,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.7759\/cureus.91470","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:16:56Z","timestamp":1756819016000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of COVID-19 on the Gut Microbiome: A Review"],"prefix":"10.7759","author":[{"given":"Andrea","family":"Pedraza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Bonnice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle N","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Demory Beckler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui J","year":"2019","unstructured":"Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019, 17:181-92. 10.1038\/s41579-018-0118-9","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming I","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004, 203:631-7. 10.1002\/path.1570","journal-title":"J Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320926","article-title":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms","volume":"69","author":"Jin X","year":"2020","unstructured":"Jin X, Lian JS, Hu JH, et al.. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020, 69:1002-9. 10.1136\/gutjnl-2020-320926","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.sjg_75_21","article-title":"Nutrition and the microbiota post-COVID-19","volume":"27","author":"Alberca GG","year":"2021","unstructured":"Alberca GG, Alberca RW. Nutrition and the microbiota post-COVID-19. Saudi J Gastroenterol. 2021, 27:111-2. 10.4103\/sjg.sjg_75_21","journal-title":"Saudi J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.2018899","article-title":"Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial","volume":"14","author":"Guti\u00e9rrez-Castrell\u00f3n P","year":"2022","unstructured":"Guti\u00e9rrez-Castrell\u00f3n P, Gandara-Mart\u00ed T, Abreu Y Abreu AT, et al.. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes. 2022, 14:2018899. 10.1080\/19490976.2021.2018899","journal-title":"Gut Microbes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00416-6","article-title":"Potential intestinal infection and faecal-oral transmission of SARS-CoV-2","volume":"18","author":"Guo M","year":"2021","unstructured":"Guo M, Tao W, Flavell RA, Zhu S. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol. 2021, 18:269-83. 10.1038\/s41575-021-00416-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-00279-z","article-title":"Coronaviruses and gastrointestinal diseases","volume":"7","author":"Luo X","year":"2020","unstructured":"Luo X, Zhou GZ, Zhang Y, Peng LH, Zou LP, Yang YS. Coronaviruses and gastrointestinal diseases. Mil Med Res. 2020, 7:49. 10.1186\/s40779-020-00279-z","journal-title":"Mil Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.039","article-title":"Current knowledge and research priorities in the digestive manifestations of COVID-19","volume":"18","author":"Aroniadis OC","year":"2020","unstructured":"Aroniadis OC, DiMaio CJ, Dixon RE, et al.. Current knowledge and research priorities in the digestive manifestations of COVID-19. Clin Gastroenterol Hepatol. 2020, 18:1682-4. 10.1016\/j.cgh.2020.04.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.588711","article-title":"Prevalence, mechanisms, and implications of gastrointestinal symptoms in COVID-19","volume":"7","author":"Perisetti A","year":"2020","unstructured":"Perisetti A, Goyal H, Gajendran M, Boregowda U, Mann R, Sharma N. Prevalence, mechanisms, and implications of gastrointestinal symptoms in COVID-19. Front Med (Lausanne). 2020, 7:588711. 10.3389\/fmed.2020.588711","journal-title":"Front Med (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.03.043","article-title":"Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19)","volume":"18","author":"Luo S","year":"2020","unstructured":"Luo S, Zhang X, Xu H. Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). Clin Gastroenterol Hepatol. 2020, 18:1636-7. 10.1016\/j.cgh.2020.03.043","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12811","article-title":"Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions","volume":"6","author":"Norouzi Masir M","year":"2022","unstructured":"Norouzi Masir M, Shirvaliloo M. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions. JGH Open. 2022, 6:667-76. 10.1002\/jgh3.12811","journal-title":"JGH Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers MM","year":"2020","unstructured":"Lamers MM, Beumer J, van der Vaart J, et al.. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020, 369:50-4. 10.1126\/science.abc1669","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1729071","article-title":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","volume":"9","author":"Zhang W","year":"2020","unstructured":"Zhang W, Du RH, Li B, et al.. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020, 9:386-9. 10.1080\/22221751.2020.1729071","journal-title":"Emerg Microbes Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2022.01.003","article-title":"SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway","volume":"568","author":"Xu H","year":"2022","unstructured":"Xu H, Akinyemi IA, Chitre SA, Loeb JC, Lednicky JA, McIntosh MT, Bhaduri-McIntosh S. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway. Virology. 2022, 568:13-22. 10.1016\/j.virol.2022.01.003","journal-title":"Virology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000750","article-title":"Current understanding of dysbiosis in disease in human and animal models","volume":"22","author":"DeGruttola AK","year":"2016","unstructured":"DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016, 22:1137-50. 10.1097\/MIB.0000000000000750","journal-title":"Inflamm Bowel Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa709","article-title":"Alterations of the gut microbiota in patients with coronavirus disease 2019 or h1 n1 influenza","volume":"71","author":"Gu S","year":"2020","unstructured":"Gu S, Chen Y, Wu Z, et al.. Alterations of the gut microbiota in patients with coronavirus disease 2019 or h1 n1 influenza. Clin Infect Dis. 2020, 71:2669-78. 10.1093\/cid\/ciaa709","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala SM","year":"2015","unstructured":"Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015, 21:8787-803. 10.3748\/wjg.v21.i29.8787","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.BAD-0010-2016","article-title":"Bifidobacteria and their health-promoting effects","volume":"5","author":"Hidalgo-Cantabrana C","year":"2017","unstructured":"Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, S\u00e1nchez B, Margolles A. Bifidobacteria and their health-promoting effects. Microbiol Spectr. 2017, 5:10.1128\/microbiolspec.BAD-0010-2016","journal-title":"Microbiol Spectr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium prausnitzii and human intestinal health","volume":"16","author":"Miquel S","year":"2013","unstructured":"Miquel S, Mart\u00edn R, Rossi O, et al.. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013, 16:255-61. 10.1016\/j.mib.2013.06.003","journal-title":"Curr Opin Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9061292","article-title":"Gut dysbiosis and IL-21 response in patients with severe COVID-19","volume":"9","author":"Khan M","year":"2021","unstructured":"Khan M, Mathew BJ, Gupta P, Garg G, Khadanga S, Vyas AK, Singh AK. Gut dysbiosis and IL-21 response in patients with severe COVID-19. Microorganisms. 2021, 9:10.3390\/microorganisms9061292","journal-title":"Microorganisms"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000003005","article-title":"The effect of Helicobacter pylori on the presentation and clinical course of coronavirus disease 2019 infection","volume":"72","author":"Balamtekin N","year":"2021","unstructured":"Balamtekin N, Artuk C, Arslan M, G\u00fcl\u015fen M. The effect of Helicobacter pylori on the presentation and clinical course of coronavirus disease 2019 infection. J Pediatr Gastroenterol Nutr. 2021, 72:511-3. 10.1097\/MPG.0000000000003005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132903","article-title":"Modulation of gut microbiota for the prevention and treatment of COVID-19","volume":"10","author":"Chen J","year":"2021","unstructured":"Chen J, Vitetta L. Modulation of gut microbiota for the prevention and treatment of COVID-19. J Clin Med. 2021, 10:10.3390\/jcm10132903","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2016.176","article-title":"Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics","volume":"11","author":"Lopez-Siles M","year":"2017","unstructured":"Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 2017, 11:841-52. 10.1038\/ismej.2016.176","journal-title":"ISME J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110947","article-title":"SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role","volume":"133","author":"Din AU","year":"2021","unstructured":"Din AU, Mazhar M, Waseem M, et al.. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother. 2021, 133:110947. 10.1016\/j.biopha.2020.110947","journal-title":"Biomed Pharmacother"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202010_23448","article-title":"COVID-19 - gastrointestinal and gut microbiota-related aspects","volume":"24","author":"Ka\u017amierczak-Siedlecka K","year":"2020","unstructured":"Ka\u017amierczak-Siedlecka K, Vitale E, Makarewicz W. COVID-19 - gastrointestinal and gut microbiota-related aspects. Eur Rev Med Pharmacol Sci. 2020, 24:10853-9. 10.26355\/eurrev_202010_23448","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.09.028","article-title":"Prebiotics and probiotics in digestive health","volume":"17","author":"Quigley EM","year":"2019","unstructured":"Quigley EM. Prebiotics and probiotics in digestive health. Clin Gastroenterol Hepatol. 2019, 17:333-44. 10.1016\/j.cgh.2018.09.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9081605","article-title":"Gut dysbiosis during COVID-19 and potential effect of probiotics","volume":"9","author":"Hung YP","year":"2021","unstructured":"Hung YP, Lee CC, Lee JC, Tsai PJ, Ko WC. Gut dysbiosis during COVID-19 and potential effect of probiotics. Microorganisms. 2021, 9:10.3390\/microorganisms9081605","journal-title":"Microorganisms"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1290756","article-title":"Dietary fiber and prebiotics and the gastrointestinal microbiota","volume":"8","author":"Holscher HD","year":"2017","unstructured":"Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017, 8:172-84. 10.1080\/19490976.2017.1290756","journal-title":"Gut Microbes"},{"key":"ref29","unstructured":"Synbiotic therapy of gastrointestinal symptoms during COVID-19 infection | Medical University of Graz. (2020). Accessed. October 15, 2022 : https:\/\/ctv.veeva.com\/study\/synbiotic-therapy-of-gastrointestinal-symptoms-during-covid-19-infection."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-02583-7","article-title":"Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients","volume":"15","author":"Liu F","year":"2021","unstructured":"Liu F, Ye S, Zhu X, et al.. Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep. 2021, 15:60. 10.1186\/s13256-020-02583-7","journal-title":"J Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/193196-impact-of-covid-19-on-the-gut-microbiome-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:16:58Z","timestamp":1756819018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/193196-impact-of-covid-19-on-the-gut-microbiome-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.91470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,2]]}}}